The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical-damaged chondrocytes

Osteoarthritis and Cartilage

Volumn 11, Issue 3, 2003, Pages 208-216

  Brun, P ^a   Panfilo, S ^a   Gordini, D Daga ^a   Cortivo, R ^a   Abatangelo, Giovanni ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CD44; Chondrocytes; Hyaluronan

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; HYDROXYL RADICAL; HYPOXANTHINE; LYMPHOCYTE ANTIGEN RECEPTOR; XANTHINE OXIDASE;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL DAMAGE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; ELECTRON MICROSCOPY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0037341741     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1063-4584(02)00352-7     Document Type: Article

References (54)

1. Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: an overview. Immunol Cell Biol 1996;74:A1-7.
2. Chen WYJ, Abatangelo G. The functions of hyaluronan in wound repair - a review. Wound Repair Regen 1999;7:1067-127.
3. Balazs EA, Denlinger JLC. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993;20(Suppl 39):3-9.
4. Peyron JG. Intra-articular hyaluronan injection in the treatment of osteoarthritis: state of the art review. J Rheumatol 1993;20(Suppl 39):10-5.
5. Engstrom-Laurent A. Hyaluronan in joint disease. J Intern Med 1997;242(1):57-60.
6. Kueter KE. Osteoarthritis: cartilage integrity and homeostasis. In: Klippel JH, Dieppe P, Eds. Rheumatology. St. Louis: Mosby 1994;6-11.
7. Knudson CB. Hyaluronan receptor directed assembly of chondrocyte pericellular matrix. J Cell Biol 1993;120:825-34.
8. Salter DM, Godolphin JL, Gourlay MS, Lawson NF, Hughes DE, Dunne E. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol 1996;179:396-402.
9. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
10. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill C. The hyaluronate receptor is a member of the CD44 (H-CD44) family of cell surface glycoproteins. J Cell Biol 1990;111:2765-74.
11. Aruffo C. CD44: one ligand, two function. J Clin Invest 1996;98:2191-2.
12. Knudson W, Knudson CB. Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. J Cell Sci 1991;99:227-35.
13. Knudson CB, Aguiar DJ, Hua Q, Knudson CB. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp Cell Res 1996;228:216-28.
14. Entwistle J, Hall CL, Turley EA. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996;61:569-77.
15. Agren U, Tolg C, Paiwand F, Turley SA, Harrison R, Turley EA. The extracellular matrix receptors CD44 and RHAMMM regulate signalling pathways leading to tumor cell motility and invasion. In: Abatangelo G, Weigel PH, Eds. New frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam: Elsevier 2000;63-76.
16. Nishida Y, D'Souza A, Thonar EJ, Knudson W. Stimulation of hyaluronan metabolism by interleukin-1a in human articular cartilage. Arthritis Rheum 2000;43:1315-26.
17. Ishida O, Tanaka Y, Morimoto I, Takigawa M, Eto S. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J Bone Miner Res 1997;12:1657-63.
18. Loveridge N, Farquharson C, Thorp BH. The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-beta and the proto-oncogene c-myc. J Cell Sci 1993;105:949-56.
19. Smith GN, Meyers SL, Brandt KD, Mickler EA. Effect of intraarticular hyaluronan injection in experimental canine ostheosrthritis. Arthritis Rheum 1998;41:976-85.
20. Moseley R, Waddington RJ, Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim Biophys Acta 1997;362:221-31.
21. Hawkins CL, Davies MJ. Degradation of hyaluronic acid, poly-and monosaccharides, and model compounds by hypochlorite: evidence for radical intermediates and fragmentation. Free Radic Biol Med 1998;24:1396-410.
22. Fragonas E, Pollesello P, Mlinarik V, Toffanin R, Grando C, Godeas C, et al. Sensitivity of chondrocytes of growing cartilage to reactive oxygen species. Biochim Biophys Acta 1998;1425:103-11.
23. Cao L, Yang BB. Chondrocyte apoptosis induced by aggrecan G1 domain as a result of decreased cell adhesion. Exp Cell Res 1999;246:527-37.
24. Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician 2000;62:565-70.
25. Ghosh P, Holbert C, Read R, Armstrong S. Hyaluronic acid (hyaluronan) in experimental osteoarthritis. J Rheumatol Suppl 1995;43:155-7.
26. Presti D, Scott JE. Hyaluronan mediated protective effect against cell damage caused by enzymatically generated hydroxyl radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994;12:281-8.
27. Cortivo R, Brun P, Cardarelli L, O'Regan M, Radice M, Abatangelo G. Antioxidant effects of hyaluronan and its alpha-methyl-prednisolone derivative in chondrocyte and cartilage cultures. Semin Arthritis Rheum 1996;26:492-501.
28. Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 1989;7:247-50.
29. Iwauta H. Pharmacologic and clinical aspects of intra-articular injection of hyaluronate. Clin Orthop 1993;289:285-91.
30. Fraser JRE, Kimton WG, Pierscioner BK, Cahill RNP. The kinetics of hyaluronan in normal and acutely inflammed synovial joints: exploratory observations with experimental arthritis in sheep. Semin Arthritis Rheum 1993;22(Suppl 1):9-17.
31. Mensiteri M, Ambrosio L, Innance S, Perbi A, Nicolais L. Viscoelastic evaluation of different knee osteoarthritis therapies. J Mater Sci Mater Med 1995;6:130-7.
32. Lindholm A, Roneus B, Lindblad G, Jones B. Hyaluronan turnover in the synovial fluid in metacarpophalangeal and middle carpal joints of standard bred horses. Acta Vet Scand 1996;37:147-51.
33. Abatangelo G, Botti P, Del Bue M, Gei G, Samson JC, Cortivo R. Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osetoarthritis in dogs. I. Biochemical results. Clin Orthop 1989;241:278-85.
34. Schiavinato A, Lini E, Guidolin D, Pezzoli G, Botti P, Martelli M. Intra-articular Na-HA injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II Morphological findings. Clin Orthop 1989;241:280.
35. Altman RD, Moskowitz R. Hyalgan Study group. Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteo-arthritis of the knee: a randomized clinical trial. J Rheum 1998;25:2203-12.
36. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet S, Wilson D, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan®) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5:153-60.
37. Fiorentini R. Proceedings of the United States Food and Drug Administration Advisory Panel on Orthopaedic and Rehabilitation Devices, 11/21/96. Fairfax (VA): Caset Associates 1996.
38. Brun P, Abatangelo G, Radice M, Zacchi V, Guidolin D, Daga Gordini D, et al. Chondrocyte aggregation and reorganization into three-dimensional scaffolds. J Biomed Mater Res 1999;46:37-46.
39. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. J Immunol Methods 1986;89:271-7.
40. Luft RM. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 1961;9:409-14.
41. Bajorath J. Molecular Organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Protein Struct Funct Genet 2000;39:103-11.
42. Yoneda M, Yamagata M, Suzuki S, Kimata K. Hyaluronic acid modulates proliferation of mouse dermal fibroblasts in culture. J Cell Sci 1988;90:265-73.
43. Goldberg R, Toole BP. Hyaluronate inhibition of cell proliferation. Arthritis Rheum 1987;30:769-75.
44. Toole BP. HA in morphogenesis and tissue remodelling: www.glycoforum.gr.jp/science/hyaluronan/HA08/HA08E1999.
45. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, et al. Anti-fas-induced apoptosis in chondrocytes reduced by hyaluronan. Arthritis Rheum 2001;44:1800-7.
46. Sherman L, Sleeman J, Herrlich P, Ponta H. HA receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994;6:726-33.
47. Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 1993;106:365-75.
48. Mc Kee CM, Penno MB, Cowman M, Bao C, Noble PW. Hyaluronan (HA) fragments induces chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996;98:2403-13.
49. Fukuda K, Takayama M, Ueno M, Oh M, Asada S, Kumano F, et al. Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes. Inflamm Res 1997;46:114-7.
50. Babior BM. Phagocytes and oxidative stress. Am J Med 2000;109:33-4.
51. Hampton MB, Kelle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants myeloperoxidase and bacterial killing. Blood 1998;92:3007-17.
52. Beales IL. Effect of interleukin-1β on proliferation of gastric epithelial cells in culture. BMC Gastroenterol 2002;2:7-15.
53. Wagner U, Burkhardt E, Falling K. Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the 3H-thymidine incorporation assay. Vet Immunol Immunopathol 1999;70:151-9.
54. Widestrand J, Lundh T, Petterson H, Lindberg JE. Cytotoxicity of four trichothecenes evaluated by three colorimetric bioassays. Mycopathologia 1999;147:149-55.